Erratum: Glycans of Antibodies as a Specific Site for Drug Conjugation Using Glycosyltransferases (Bioconjugate Chem (2015) 26:11 (2170-2175) DOI:10.1021/acs.bioconjchem.5b00173);Glycans of Antibodies as a Specific Site for Drug Conjugation Using Glycosyltransferases

Bioconjugate Chemistry

Volumn 26, Issue 11, 2015, Pages 2170-2175

  Qasba, Pradman K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; ENZYMES; MOLECULES; POLYSACCHARIDES;

ANTIBODY-DRUG CONJUGATES; BIOCONJUGATES; CARGO MOLECULES; CYSTEINE RESIDUES; GLYCANS; GLYCOSYL TRANSFERASE; GLYCOSYLATED; LYSINE RESIDUES; SITE-SPECIFIC; SPECIFIC SITES;

MONOCLONAL ANTIBODIES;

ANTIBODY DRUG CONJUGATE; BETA 1,4 GALACTOSYLTRANSFERASE; GALACTOSYLTRANSFERASE; GLYCAN DERIVATIVE; GLYCOSYLTRANSFERASE; IMMUNOGLOBULIN G1; MONOCLONAL ANTIBODY; MUTANT PROTEIN; SIALIC ACID; UNCLASSIFIED DRUG; ANTIBODY CONJUGATE; IMMUNOGLOBULIN G; N ACETYLNEURAMINIC ACID; POLYSACCHARIDE;

ANTIBODY COMBINING SITE; ARTICLE; CARBOHYDRATE ANALYSIS; DRUG CONJUGATION; DRUG TARGETING; HUMAN; MUTANT; NONHUMAN; SUGAR TRANSPORT; WILD TYPE; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; GLYCOSYLATION; METABOLISM; MOLECULAR GENETICS; MUTATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CARBOHYDRATE SEQUENCE; GLYCOSYLATION; GLYCOSYLTRANSFERASES; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULIN G; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; N-ACETYLNEURAMINIC ACID; POLYSACCHARIDES;

EID: 84947786749     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/acs.bioconjchem.5b00658     Document Type: Erratum

References (39)

1. Garnett, M. C. (2001) Targeted drug conjugates: principles and progress Adv. Drug Delivery Rev. 53, 171-216
2. Wu, A. W. and Senter, P. D. (2005) Arming antibodies: prospects and challenges for immunoconjugates Nat. Biotechnol. 23, 1137-1146
3. Sharkey, R. M. and Goldenberg, D. M. (2008) Use of antibodies and immunoconjugates for the therapy of more accessible cancers Adv. Drug Delivery Rev. 60, 1407-1420
4. Stephanopoulos, N. and Francis, M. B. (2011) Choosing an effective protein bioconjugation strategy Nat. Chem. Biol. 7, 876-884
5. Behrens, C. B. and Liu, B. (2014) Methods for site-specific drug conjugation to antibodies MAbs 1, 46-53
6. Agarwal, P. and Bertozzi, C. R. (2015) Site-specific antibody-drug conjugates: The nexus of bioorthogonal chemistry, protein engineering, and drug development Bioconjugate Chem. 26, 176-192
7. Hamblett, K. J., Senter, P. D., Chace, D. F., Sun, M. M. C., Lenox, J., Cerveny, C. G., Kissler, K. M., Bernhardt, S. X., Kopcha, A. K., and Zabinski, R. F. et al. 2004, Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate Clin. Cancer Res. 10, 7063-7070
8. Wang, L., Amphlett, G., Blättler, W. A., Lambert, J. M., and Zhang, W. (2005) Structural characterization of the maytansinoid-monoclonal antibody immunoconjugate, huN901-DM1, by mass spectrometry Protein Sci. 14, 2436-2446
9. Senter, P. D. and Sievers, E. L. (2012) The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma Nat. Biotechnol. 30, 631-637
10. Sun, M. M. C., Beam, K. S., Cerveny, C. G., Hamblett, K. J., Blackmore, R. S., Torgov, M. Y., Handley, F. G. M., Ihle, N. C., Senter, P. D., and Alley, S. C. (2005) Reduction-alkylation strategies for the modification of specific monoclonal antibody disulfides Bioconjugate Chem. 16, 1282-1290
11. Bross, P. F., Beitz, J., Chen, G., Chen, X. H., Duffy, E., Kieffer, L., Roy, S., Sridhara, R., Rahman, A., Williams, G., and Pazdur, R. (2001) Gemtuzumab ozogamicin in relapsed acute myeloid leukemia Clin. Cancer Res. 7, 1490-1496
12. Jackson, D., Atkinson, J., Guevara, C. I., Zhang, C., Kery, V., Moon, S. J., Virata, C., Yang, P., Lowe, C., and Pinkstaff, J. et al. 2014, In vitro and in vivo evaluation of cysteine and site specific conjugated herceptin antibody-drug conjugates PLoS One 9, e83865
13. Junutula, J. R., Bhakta, S., Raab, H., Ervin, K. E., Eigenbrot, C., Vandlen, R., Scheller, R. H., and Lowman, H. B. (2008) Rapid identification of reactive cysteine residues for site-specific labeling of antibody-Fabs J. Immunol. Methods 332, 41-52
14. Kline, T., Steiner, A. R., Penta, K., Sato, A. K., Hallam, T. J., and Yin, G. (2014) Methods to make homogeneous antibody drug conjugates Pharm. Res. 10.1007/s11095-014-1596-8
15. Hofer, T., Skeffington, L. R., Chapman, C. M., and Rader, C. (2009) Molecularly defined antibody conjugation through a selenocysteine interface Biochemistry 48, 12047-12057
16. Raju, T. S. (2008) Terminal sugars of Fc glycans influence antibody effector functions of IgGs Curr. Opin. Immunol. 20, 471-478
17. Jefferis, R. (2005) Glycosylation of recombinant antibody therapeutics Biotechnol. Prog. 21, 11-16
18. O'Shannessy, D. J. and Quarles, R. H. (1971) Labeling of the oligosaccharide moieties of immunoglobulins J. Immunol. Methods 99, 153-161
19. Van Lenten, L. and Ashwell, G. (1971) Studies on the chemical and enzymatic modifications of glycoproteins. A general method for the tritiation of sialic acid-containing glycoprotein J. Biol. Chem. 246, 1889-1894
20. Chua, M., Fan, S., and Karush, F. (1984) Attachment of immunoglobulin to liposomal membrane via protein carbohydrate Biochim. Biophys. Acta 800, 291-300
21. O'Shannessy, D. J., Dobersen, M. J., and Quarles, R. H. (1984) A novel procedure for labeling immunoglobulins by conjugation to oligosaccharide moieties Immunol. Lett. 8, 273-277
22. Zhou, Q., Stefano, J. E., Manning, C., Kyazike, J., Chen, B., Gianolio, D. A., Park, A., Busch, M., Bird, J., and Zheng, X. et al. 2014, Site-specific antibody-drug conjugation through glycoengineering Bioconjugate Chem. 25, 510-520
23. Meldal, M. and Wenzel, T. C. (2008) Cu-catalyzed azide-alkyne cycloaddition Chem. Rev. 108, 2952-3015
24. Ning, X., Guo, J., Wolfert, M. A., and Boons, G. J. (2008) Visualizing metabolically labeled glycoconjugates of living cells by copper-free and fast huisgen cycloadditions Angew. Chem., Int. Ed. 47, 2253-2255
25. Li, X., Fang, T., and Boons, G. J. (2014) Preparation of well-defined antibody-drug conjugates through glycan remodeling and strain-promoted azide-alkyne cycloadditions Angew. Chem., Int. Ed. 53, 7179-7182
26. Qasba, P. K., Ramakrishnan, B., and Boeggeman, E. (2005) Substrate-induced conformational changes in glycosyltransferases Trends Biochem. Sci. 30, 53-62
27. Ramakrishnan, B. and Qasba, P. K. (2002) Structure-based design of beta-1,4-galactosyltransferase-I (beta 4Gal-T1) with equally efficient N-Acetylgalactosaminyltransferase activity: point mutation broadens beta 4Gal-T1 donor specificity J. Biol. Chem. 277, 20833-20839
28. Pasek, M., Ramakrishnan, B., Boeggeman, E., Manzoni, M., Waybright, T. J., and Qasba, P. K. (2009) Bioconjugation and detection of lactosamine moiety using α1,3-galactosyltransferase mutants that transfer C2-modified galactose with a chemical handle Bioconjugate Chem. 20, 608-618
29. Khidekel, N., Arndt, S., Lamarre-Vincent, N., Lippert, A., Poulin-Kerstien, K. G., Ramakrishnan, B., Qasba, P. K., and Hsieh- Wilson, L. C. (2003) A chemoenzymatic approach toward the rapid and sensitive detection of O-GlcNAc posttranslational modifications J. Am. Chem. Soc. 125, 16162-16163
30. Qasba, P. K., Ramakrishnan, B., and Boeggeman, E. (2008) Structure and function of beta-1,4-galactosyltransferase Curr. Drug Targets 9, 292-309
31. Boeggeman, E., Ramakrishnan, B., Kilgore, C., Khidekel, N., Hsieh-Wilson, L. C., Simpson, J. T., and Qasba, P. K. (2007) Direct identification of nonreducing GlcNAc residues on N-glycans of glycoproteins using a novel chemoenzymatic method Bioconjugate Chem. 18, 806-814
32. Boeggeman, E., Ramakrishnan, B., Pasek, M., Manzoni, M., Puri, A., Loomis, K. H., Waybright, T. J., and Qasba, P. K. (2009) Site specific conjugation of fluoroprobes to the remodeled Fc N-glycans of monoclonal antibodies using mutant glycosyltransferases: application for cell surface antigen detection Bioconjugate Chem. 20, 1228-1236
33. Ramakrishnan, B., Boeggeman, E., Pasek, M., and Qasba, P. K. (2011) Bioconjugation using mutant glycosyltransferases for the site-specific labeling of biomolecules with sugars carrying chemical handles Methods Mol. Biol. 751, 281-296
34. Qasba, P. K., Boeggeman, E., and Ramakrishnan, B. (2008) Site-specific linking of biomolecules via glycan residues using glycosyltransferases Biotechnol. Prog. 24, 520-526
35. Ramakrishnan, B., Boeggeman, E., and Qasba, P. K. (2008) Applications of glycosyltransferases in the site-specific conjugation of biomolecules and development of a targeted drug delivery system and contrast agents for MRI Expert Opin. Drug Delivery 5, 149-153
36. Zhu, Z., Ramakrishnan, B., Li, J., Wang, Y., Feng, Y., Prabakaran, P., Colantonio, S., Dyba, M. A., Qasba, P. K., and Dimitrov, S. D. (2014) Site-specific antibody-drug conjugation through an engineered glycotransferase and a chemically reactive sugar MAbs 6, 1190-1200
37. Sletten, E. M. and Bertozzi, C. R. (2009) Bioorthogonal chemistry: fishing for selectivity in a sea of functionality Angew. Chem., Int. Ed. 48, 6974-6998
38. Zeglis, B. M., Davis, C. B., Aggeler, R., Kang, H. C., Chen, A., Agnew, B. J., and Lewis, J. S. (2013) Enzyme-mediated methodology for the site-specific radiolabeling of antibodies based on catalyst-free click chemistry Bioconjugate Chem. 24, 1057-1067
39. Zeglis, B. M., Davis, C. B., Abdel-Atti, D., Carlin, S. D., Chen, A., Aggeler, R., Agnew, B. J., and Lewis, J. S. (2014) Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imaging Bioconjugate Chem. 25, 2123-2128